Ledger.Open graph →
SEC Form D · filed October 14, 2016

Castle Creek Pharmaceuticals, LLC

Offering
$48.0M
Sold
$48.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
BEDMINSTER, NJ
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Patrick Morris · BEDMINSTER, NJDirectorJeffrey Aronin · BEDMINSTER, NJDirectorTimothy Cunniff · BEDMINSTER, NJDirectorGreg Licholai · BEDMINSTER, NJExecAntonio Gracias · BEDMINSTER, NJDirectorMichael Derby · BEDMINSTER, NJExec · DirectorVincent Campagna · NEW YORK, NYDirectorFergus Healy · NEW YORK, NYExecKent Roers · Long Lake, MNDirectorRussell Valdez · NEW YORK, NYDirectorFawaz Al-Mubaraki · NEW YORK, NYExec · DirectorMichael Shedosky · NEW YORK, NYDirectorOctagon Capital Group, Llc · Millburn, NJPromoterSusan G. O'Connell · Boston, MADirectorMatthew N. Shea · Boston, MADirectorJoshua Katz · New York, NYDirectorBrett Anderson · Broomfield, COExecJerry Dinges · Broomfield, COExec · DirectorMichael Sarkesian · Broomfield, CODirectorOctagon Capital Group, Llc · Millburn, NJPromoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗